We offer a packaged suite of tests for assisting with diagnosing and monitoring retinal toxicity due to Plaquenil. Current international guidelines recommend baseline ophthalmic assessment before initiation of treatment and then screening after 5 years. Indications for more regular screening include...See more
Headquarters:
Australia
Company Type:
SME
Company size:
Employees
Address:
null
LOW
spending power
